## **Core Concept**
The half-life of a biological substance, in this case, factor VIII, refers to the time it takes for the concentration of that substance to reduce by half. Factor VIII is a crucial protein in the blood clotting cascade, and its deficiency leads to hemophilia A. Understanding the half-life of factor VIII is essential for managing patients with hemophilia A, as it influences the frequency of factor VIII replacement therapy.

## **Why the Correct Answer is Right**
The correct half-life of factor VIII is approximately 8 to 12 hours. This relatively short half-life necessitates frequent administration of factor VIII concentrates to maintain therapeutic levels in patients with hemophilia A. The half-life can vary slightly among individuals and may be influenced by several factors, including the presence of inhibitors, the type of factor VIII product used (e.g., recombinant vs. plasma-derived), and patient-specific factors.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because the half-life of factor VIII is significantly longer than a few minutes, which would not be clinically useful for replacement therapy.
- **Option B:** This option suggests a half-life of several days, which is too long for factor VIII and does not align with clinical practice or pharmacokinetic data.
- **Option D:** This option suggests a half-life that is too long compared to the established pharmacokinetics of factor VIII.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that the half-life of factor VIII can be used to guide prophylactic and therapeutic dosing strategies. For example, in patients with hemophilia A, factor VIII levels need to be maintained above 1% to prevent spontaneous bleeding, which often requires dosing every 12-24 hours depending on the severity of the deficiency and the patient's specific needs.

## **Correct Answer:** B. 8-12 hours.